Why do patients meeting criteria for borderline personality disorder deliberately harm themselves? Some hypothesised neurobiological correlates †
Summary
Introduction
Clinical description
Hypothesis
Neurobiological mechanisms associated with separation distress
Endogenous opiate system and stress responses
Peripheral and central neuronal mechanisms activated by deliberate self-harm
Opiate antagonists in the treatment of deliberate self-harm
Discussion
Conclusion
References
- American Psychiatric Association (Ed.) Diagnostic and statistical manual of mental disorders, 4th ed.; American Psychiatric Association: Washington, DC, 1994. [Google Scholar]
- Hyman, SE. A new beginning for research on borderline personality disorder. Biol Psychiatry 2002, 51, 933–5. [Google Scholar] [CrossRef] [PubMed]
- Welch, S; Linehan, MM. High-risk situations associated with parasuicide and drug use in borderline personality disorder. J Personal Disord 2002, 16, 561–9. [Google Scholar] [CrossRef] [PubMed]
- Linehan, MM. Suicidal people, one population or two? Ann N Y Acad Sci 1986, 487, 16–33. [Google Scholar] [CrossRef] [PubMed]
- Hawton K, Townsend E, Arensman E, Gunnell D, Hazell P, House A, et al. Psychosocial and pharmacological treatments for deliberate self-harm. The Cochrane Library 2001, library number CD001764.
- Crowe, M; Bunclark, J. Repeated self-injury and its management. Int Rev Psychiatry 2000, 12, 48–53. [Google Scholar]
- Coid, J; Allolio, B; Rees, LH. Raised plasma metenkephalin in patients who habitually mutilate themselves. Lancet 1983, 2, 545–6. [Google Scholar] [CrossRef] [PubMed]
- Simpson, MA. The phenomenology of self-mutilation in a general hospital setting. Can Psychiatr Assoc J 1975, 206, 429–33. [Google Scholar] [CrossRef] [PubMed]
- Panksepp, J. Affective Neuroscience: The Foundations of Human and Animal Emotions; Oxford University Press: New York, etc., 1998. [Google Scholar]
- Insel, TR; Winslow, JT. The neurobiology of social attachment. In Neurobiology of Mental Illness; Charney, DS, Nestler, EJ, Bunney, BS, Eds.; Oxford University Press: New York, etc., 1999; pp. 880–90. [Google Scholar]
- Nelson, EE; Panksepp, J. Brain substrates of infant-mother attachment: contributions of opioids, oxytocin, and norepinephrine. Neurosci Biobehav Rev 1998, 22, 437–52. [Google Scholar] [CrossRef] [PubMed]
- Kraemer, GW. A psychobiological theory of attachment. Behav Brain Sci 1992, 15, 493–541. [Google Scholar] [CrossRef] [PubMed]
- Liotti, G; Pasquini, P. Predictive factors for borderline personality disorder: patients’ early traumatic experiences and losses suffered by the attachment figure. The Italian Group for the Study of Dissociation. Acta Psychiatr Scand 2000, 102, 282–9. [Google Scholar] [CrossRef] [PubMed]
- Jessell, TM; Kelly, DD. Pain and analgesia. In Principles of Neural Science, 3rd ed.; Kandel, ER, Schwartz, JH, Jessell, TM, Eds.; Elsevier: New York, etc., 1991; pp. 385–99. [Google Scholar]
- Norman, AW; Litwack, G. Anterior Pituitary Hormones. In Hormones; Norman, AW, Litwack, G, Eds.; Academic Press: San Diego, etc., 1997; pp. 133–68. [Google Scholar]
- Dinan, TG. Neuroendocrinology. In Understanding the Biology of Mental Disorders; Dinan, TG, Ed.; Science Press: London, 1997; pp. 32–40. [Google Scholar]
- Solomon, S. POMC-derived peptides and their biological action. Ann N Y Acad Sci 1999, 885, 22–40. [Google Scholar] [CrossRef] [PubMed]
- Brown, P. Toward a psychobiological model of dissociation and post-traumatic stress disorder. In Dissociation: Clinical and Theoretical Perspectives; Lynn, SJ, Rhue, JW, Eds.; Guilford Press: New York, etc., 1994; pp. 94–112. [Google Scholar]
- Raja, SN; Meyer, RA; Ringkamp, M; Campbell, JN. Peripheral neural mechanisms of nociception. In Textbook of Pain, 4th ed.; Wall, PD, Melzack, R, Eds.; Churchill Livingston: Edinburgh, etc., 1999; pp. 331–43. [Google Scholar]
- Chapman, CR. The affective dimension of pain: a model. In Pain and the Brain: from Nociception to Cognition. Advances in Pain Research and Therapy; Bromm, B, Desmedt, JE, Eds.; Raven Press Ltd.: New York, 1995; Vol. 22. [Google Scholar]
- Chapman, CR. Limbic processes and the affective dimension of pain. In Progress in Brain Research; Carli, G, Zimmerman, M, Eds.; Elsevier Science B.V.: Amsterdam, etc., 1996; Vol. 110. [Google Scholar]
- Craig, KD. From nociception to pain: the role of emotion. In Pain and the Brain: From Nociception to Cognition. Advances in Pain Research and Therapy; Bromm, B, Desmedt, JE, Eds.; Raven Press Ltd.: New York, 1995; Vol. 22. [Google Scholar]
- Craig, KD. Emotions and psychobiology. In Textbook of Pain, 4th ed.; Wall, PD, Melzack, R, Eds.; Churchill Livingston: Edinburgh, etc., 1999; pp. 11–57. [Google Scholar]
- Reneric, JP; Bouvard, MP. Opioid receptor antagonists in psychiatry, beyond drug addiction. CNS Drugs 1998, 10, 365–82. [Google Scholar]
- Buzan, RD; Thomas, M; Dubovsky, SL; Treadway, J. The use of opiate antagonists for recurrent self-injurious behavior. J Neuropsychiatry Clin Neurosci 1995, 7, 437–44. [Google Scholar] [PubMed]
- Griengl, H; Sendera, A; Dantendorfer, K. Naltrexone as a treatment of self-injurious behavior – a case report. Acta Psychiatr Scand 2001, 103, 234–6. [Google Scholar] [CrossRef] [PubMed]
- Sandman, CA; Hetrick, W; Taylor, D; Marion, S; ChiczDeMet, A. Uncoupling of proopiomelanocortin (POMC) fragments is related to self-injury. Peptides 2000, 21, 785–91. [Google Scholar] [CrossRef] [PubMed]
- Malcolm, R; O’Neil, PM; Von, JM; Dickerson, PC. Naltrexone and dysphoria: a double-blind placebo controlled trial. Biol Psychiatry 1987, 22, 710–6. [Google Scholar] [CrossRef] [PubMed]
- Schlaepfer, TE; Strain, EC; Greenberg, BD; Preston, KL; Lancaster, E; Bigelow, GE; et al. Site of opioid action in the human brain: mu and kappa agonists’ subjective and cerebral blood flow effects. Am J Psychiatry 1998, 155, 470–3. [Google Scholar] [CrossRef] [PubMed]
- Hadjistavropoulos, T; McMurty, B; Craig, KD. Beautiful faces in pain: biases and accuracy in the perception of pain. Psychology and Health 1996, 11, 411–20. [Google Scholar] [CrossRef]
- Price, DD. Psychological and neural mechanisms of the affective dimension of pain. Science 2000, 288, 1769–72. [Google Scholar] [CrossRef] [PubMed]
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
Share and Cite
McQuillan, A. Why do patients meeting criteria for borderline personality disorder deliberately harm themselves? Some hypothesised neurobiological correlates. Swiss Arch. Neurol. Psychiatry Psychother. 2004, 155, 212-216. https://doi.org/10.4414/sanp.2004.01494
McQuillan A. Why do patients meeting criteria for borderline personality disorder deliberately harm themselves? Some hypothesised neurobiological correlates. Swiss Archives of Neurology, Psychiatry and Psychotherapy. 2004; 155(5):212-216. https://doi.org/10.4414/sanp.2004.01494
Chicago/Turabian StyleMcQuillan, Annabel. 2004. "Why do patients meeting criteria for borderline personality disorder deliberately harm themselves? Some hypothesised neurobiological correlates" Swiss Archives of Neurology, Psychiatry and Psychotherapy 155, no. 5: 212-216. https://doi.org/10.4414/sanp.2004.01494
APA StyleMcQuillan, A. (2004). Why do patients meeting criteria for borderline personality disorder deliberately harm themselves? Some hypothesised neurobiological correlates. Swiss Archives of Neurology, Psychiatry and Psychotherapy, 155(5), 212-216. https://doi.org/10.4414/sanp.2004.01494
